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ABSTRACT
The expression of ribosomal protein (rp) genes
is regulated at multiple levels. In yeast, two genes
are autoregulated by feedback effects of the protein
on pre-mRNA splicing. Here, we have investigated
whether similar mechanisms occur in eukaryotes
with more complicated and highly regulated splicing
patterns. Comparisons of the sequences of riboso-
mal protein S13 gene (RPS13) among mammals and
birds revealed that intron 1 is more conserved than
the other introns. Transfection of HEK 293 cells with
a minigene-expressing ribosomal protein S13
showed that the presence of intron 1 reduced
expression by a factor of four. Ribosomal protein
S13 was found to inhibit excision of intron 1 from
rpS13 pre-mRNA fragment in vitro. This protein was
shown to be able to specifically bind the frag-
ment and to confer protection against ribonuclease
cleavage at sequences near the 5’ and 3’ splice
sites. The results suggest that overproduction of
rpS13 in mammalian cells interferes with splicing
of its own pre-mRNA by a feedback mechanism.
INTRODUCTION
Apart from their functions in ribosome assembly (1) and
mRNA translation (2,3), many ribosomal proteins are
involved in a variety of extraribosomal processes (4).
There are 79 diﬀerent mammalian ribosomal proteins,
34 of which have bacterial counterparts (5). Human
ribosomal protein genes are distributed widely through
the genome and, except for ribosomal protein (rp) S4,
each protein is encoded by a single gene (5). The level of
expression of these genes depends on various factors
such as the cell type, the phase of the cell cycle, ambient
conditions, etc. (6,7). Fine regulation of ribosomal protein
biosynthesis is necessary for the vitality of individual cells
and whole organisms, and impairments of this regulation
may lead to critical consequences such as malignant
transformation (8,9), apoptosis (10,11), developmental
malformations (12,13) and so on.
It is known that the expression of ribosomal protein
genes in eukaryotes can be regulated at the levels of
transcription (5,14), translation (15) and splicing (16,17).
In addition, the content of ribosomal proteins in
eukaryotic cells is controlled via changes in the degrada-
tion rate of newly synthesized proteins (18). The
transcriptional and translational levels of the regulation
are coordinated by common regulatory elements in the
genes (5) and mRNA (19) of ribosomal proteins.
The regulation of ribosomal protein biosynthesis at the
splicing level is less well documented. In yeast, at least
two genes are regulated via a feedback mechanism in
which ribosomal proteins bind their own pre-mRNAs,
preventing their splicing (16,17,20). As for humans,
indications for the regulation of expression via splicing
were recently obtained for two rp genes. So, we demon-
strated that rpS26 suppresses splicing of its own pre-
mRNA in vitro (21). Binding of this protein to its cognate
pre-mRNA may prevent the recognition of the splicing
signals by components of the splicing machinery and thus
interfere with spliceosome assembly. However, whether
rpS26 biosynthesis is regulated this way in vivo is still
unknown. A similar pathway may be realized in the
regulation of human rpL3 biosynthesis (22). It was shown
that rpL3 overexpression caused an increase in its
aberrantly spliced mRNA that contained intron 3 and
was degraded by the nonsense-mediated decay (NMD)
pathway (23). A similar aberrantly spliced isoform of
mRNA containing unremoved intron 1 was found also
for rpL12 from Caenorhabditis elegans (24). However,
a direct implication of rpL3 and rpL12 in their biosynth-
esis regulation was not proven.
Autoregulation appears to be a potent mechanism by
which the level of each individual ribosomal protein in
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crucial for the extraribosomal functions of ribosomal
proteins. To test this possibility further, we have examined
human rpS13. This protein is a homologue of prokaryotic
rpS15, which binds to the central domain of the 16S
rRNA and promotes the binding of neighbouring proteins
in the 30S ribosomal subunit (25). Its yeast counterpart
is indispensable for the initial stage of pre-18S rRNA
processing (1). The extraribosomal functions of human
rpS13 are still unclear; nevertheless there are data
suggesting that rpS13 (along with rpL23) promotes
multidrug resistance in gastric cancer cells by suppressing
drug-induced apoptosis (26). Remarkably, of the 17
human EST records containing the sequence correspond-
ing to RPS13 intron 1 in GenBank, at least two (GenBank
accession no CD050699 and BI756632) are derived from
rpS13 mRNA containing retained intron 1. This suggested
to us that the protein might be involved in autoregulation
of its expression via splicing, so we have tested this
possibility both in vivo and in vitro.
In the current study we have analysed the extent of
conservation of intron 1 within RPS13 gene in mammals
and examined role of human rpS13 in its own gene
expression regulation. Our ﬁrst results showed that
the presence of the ﬁrst intron in an rpS13 minigene
reduced the level of mRNA expressed in cell culture.
The possibility that there was a protein-dependent
inhibition of splicing was conﬁrmed by in vitro splicing
experiments. Remarkably, the rpS13-binding sites on
the pre-mRNA turned out to be located closely to
the splice sites that allowed us to suggest a feedback
mechanism for the RPS13 gene expression regulation at
the splicing step.
MATERIALS AND METHODS
PCR and plasmid constructions
DNA sequences containing a coding part of rpS13 cDNA
were PCR ampliﬁed using total HeLa cDNA and a pair of
primers, S13F and S13R. The PCR product was digested
with PstI and BamHI and cloned in the vector pECFP-N1
(Clontech, USA), producing pECFP-S13. The DNA
fragment containing a coding part of rpS13 cDNA with
inserted intron 1 was obtained in two stages. Initially, a
DNA fragment containing intron 1 of RPS13 gene ﬂanked
with exon sequences was PCR ampliﬁed using genomic
HeLa DNA and a pair of primers, S13F and S13Rint1.
Then a second DNA fragment containing a coding part of
rpS13 cDNA excluding the sequence of exon 1 was PCR
ampliﬁed using total HeLa cDNA and primers S13Fint1
and S13R. PCR ampliﬁcation with the use of two of these
PCR products as a template and primers S13F and S13R
produced the desired DNA fragment. This DNA fragment
was digested with PstI and BamHI and cloned in the
vector pECFP-N1at the same sites of restriction produ-
cing pECFP-S13-int1. All recombinant plasmids were
veriﬁed by sequencing. The oligonucleotides used in this
work are listed in Table 1.
Cellculture transfection and real-time PCR
Human HEK 293 cells were routinely maintained at 378C
with 5% CO2 in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) containing 10% of fetal calf serum. For
transient transfections, 4 10
5 cells (70–80% conﬂuent)
were transfected with 1mg of plasmid DNA with the use
of jetPEI transfection reagent (Polyplus-transfection,
France), according to the manufacturer’s instructions.
After 18h (when the level of transfection detected by blue
ﬂuorescence was  10–15%), total RNA was isolated using
TRI reagent (Sigma, USA). Reverse transcription was
performed using 2mg of the RNA, 0.5mg (pN)6 and
M-MLV RT (Promega, USA) in according to the pro-
tocol of the enzyme manufacturer. Real-time PCR was
performed on a Corbett Rotor-Gene 3000 (Corbett,
Australia) using the Platinum SYBR Green qPCR
SuperMix (Invitrogen, USA) according to the manual of
the manufacturer. For standardization of the quantity
of RNA in the samples taken for the real-time PCR assay
a pair of primers speciﬁc to GAPDH cDNA was used.
Dispersal of amount of GAPDH cDNA in the samples
that reﬂects total amount of RNA was  25% from
average value. Experiments with cell transfection and real-
time PCR were repeated independently for three times.
Table 1. Oligodeoxynucleotides used in the study
Name Sequence (50to 30) Description
S13F GTTCTGCAGGTGGAGGTTCAATGGGTCGCATGCATGCTC pECFP-S13 construction
S13R CCAGGATCCAATGCGACCAGGGCAGAGGC pECFP-S13 construction
S13Rint1 GACTGGGACAGGCCCTTCCTGGGGAGAGAAGC pECFP-S13-int1 construction
S13Fint1 CACCTCGAGACTGCTTCTCTCCCCAGGAAGGGCCTGTCCCAGTC pECFP-S13-int1 construction
preS13F GCTAATACGACTCACTATAGGGCTTTCGTTGCCTGATCG RPS13-speciﬁc
preS13R CGCGCTACTTACAGTG RPS13-speciﬁc
preS16F TAATACGACTCACTATAGGGCCTTTTCCGGTTGCGGC RPS16-speciﬁc
preS16R GGATCCCAGCACCTTG RPS16-speciﬁc
preS17F TAATACGACTCACTATAGGGACCAAGGACCCGCCAACATGGTAGGTGTTT RPS17-speciﬁc
preS17R CCCGACTCACCCTGCTATC RPS17-speciﬁc
preS26F GGATCCTAATACGACTCACTATAGGGGTGAGTCTTCTTGCGTGGTGAG RPS26-speciﬁc
preS26R AATAGGCTGCACGTGGCCGC RPS26-speciﬁc
S13Fmut CATGCTAGAGGGTGAGCTCGGGGCATC RPS13-speciﬁc, mutant
S13Rmut CAGGCCGGGCCTGGGGAGAGAAGCAGT RPS13-speciﬁc, mutant
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The templates for synthesis of fragments of ribosomal
proteins pre-mRNAs by T7 RNA polymerase were
obtained by means of PCR using genomic HeLa DNA
and pairs of primers, namely, preS13F and preS13R
for rpS13 pre-mRNA fragment—S13INT, preS16F and
preS16R for rpS16 pre-mRNA, preS17F and preS17R for
rpS17 pre-mRNA and preS26F and preS26R for rpS26
pre-mRNA. To prepare DNA template for synthesis of
mutant S13INT (S13INTm), two mutant semi-templates
were initially obtained by PCR using primers preS13F
and S13Rmut and S13Fmut and preS13R. These semi-
templates were annealed and used in the second PCR
step with primers preS13F and preS13R. All PCR pro-
ducts were gel-puriﬁed and sequenced. Respective
RNA transcripts were synthesized in
32P-labelled (27)
and non-labelled (28) variants. Binding of
32P-labelled
S13INT (or the pre-mRNA fragments) with recombinant
rpS10 (29), S13 (30) and S16 (31) was carried out in buﬀer
(20mM Tris–HCl, pH 7.5, 10mM MgCl2, 200mM KCl,
2.5mM 2-mercaptoethanol and 0.05% Triton X-100) at
08C for 1h. Reaction mixtures were ﬁltered on
a nitrocellulose membrane with pores diameter 0.45mm.
Binding was measured as the ratio of radioactivity trapped
on the ﬁlter to the total radioactivity in the reaction
mixture. All experiments on proteins binding were at least
triplicated. The relative error in measurements was less
than 15%.
Immunoprecipitation
Recombinant rpS13 (10pmol) was pre-incubated in 30ml
of buﬀer A (50mM Tris–HCl, pH 7.5, 300mM NaCl,
1mM EDTA and 0.1% Triton X-100) containing 50%
HeLa nuclear extract (‘CCCC’, Belgium) at 308C for
5min. A mixture containing
32P-labelled RNA transcripts
(S13INT and fragments of pre-mRNAs of rpS17 and
rpS26, 0.5fmol, 2000–4000c.p.m. of each) was pre-
incubated in 20ml of the same buﬀer at 308C for 10min.
Then the pre-incubated rpS13 solution and the mixture of
the RNA transcripts were united and incubated at 208C
for 1h. Rabbit antibodies against human rpS13 puriﬁed
from speciﬁc antiserum by aﬃnity chromatography on
a column with immobilized recombinant rpS13 were
bound to 20ml of protein G-sepharose resin (Sigma,
USA) and the resin was washed with buﬀer A for ﬁve
times. The washed resin was added to the mixture
containing rpS13 and RNA transcripts and the mixture
was incubated at 08C for 1h under gentle agitation.
Finally, the resin was washed with buﬀer A for ﬁve times,
then bound proteins were eluted with 2% SDS, and RNA
transcripts were isolated by phenol deproteination and
analysed on a 6% denaturing gel.
Splicingin vitro
Splicing in vitro was performed as described in (32). Where
mentioned, reaction mixtures contained appropriate
amount of recombinant ribosomal proteins. The reaction
samples were run on a 6% denaturing polyacrylamide
gel. The ﬁxed and dried gels were then exposed to
a phosphorimager screen of Molecular Imager FX Pro
equipment (Bio-Rad, USA).
Footprinting assay
Footprinting was performed according to protocol (33)
with minor modiﬁcations. A complex of S13INT with
rpS13 was formed by incubation of 1 pmol of RNA and
30 pmol of protein in 10ml of buﬀer (20mM HEPES–
KOH, pH 7.5, 150mM KCl, 8mM MgCl2, 10mM DTT
and 0.4mg/ml total Escherichia coli tRNA) at 208C for
15min. Then reaction mixtures were incubated at the same
conditions in presence of either RNase T1 (0.5U) or
RNase T2 (0.2U) or RNase V1 (0.05U). RNAs from the
reaction mixtures were isolated by phenol deproteiniza-
tion. Nucleotides 50 to cleaved phosphodiester bonds were
determined by reverse transcription–primer extension as
described in (34).
RESULTS
Intron 1in thegene coding forrpS13 inmammals and
birds is more conservedthan other introns
Alignment and comparative analysis of the human gene
coding for rpS13 with homologous genes in the genomes
of some mammals (Canis familiaris, Rattus norvegicus,
Mus musculus) and birds (Gallus gallus) performed in the
Evolutionary Conserved Regions (ECR) Browser (http://
ecrbrowser.dcode.org) (35) revealed that intron 1 within
this gene is particularly well conserved (Figure 1). This
suggests that the region of the gene including intron 1 is
functionally signiﬁcant and may contain regulatory
sequence elements. We have investigated the possibility
that such regulation could take place at the level of
pre-mRNA splicing.
Intron-dependentreductioninrpS13mRNAinHEK293cells
To investigate the functional importance of intron 1 in the
pre-mRNA of rpS13, HEK 293 cells were transiently
transfected with plasmid constructs coding for human
rpS13 fused with a ﬂuorescent reporter protein, eCFP
(Figure 2A). The ﬁrst construction (pECFP-S13) con-
tained the coding part of rpS13 cDNA inserted into the
vector pECFP-N1 in frame with the eCFP gene. The
second construction (pECFP-S13-int1) was similar to
pECFP-S13 but contained RPS13 intron 1 inserted in
the coding part of rpS13 cDNA between sequences
corresponding to exons 1 and 2. As a control, cells were
transfected with the original vector pECFP-N1. The
rpS13-eCFP fusion protein produced in the cells trans-
fected with pECFP-S13 and pECFP-S13-int1 was nuclear
and nucleolar, as expected for ribosomal proteins over-
expressed in eukaryotic cells (36,37). The relative amount
of the mRNA coding for rpS13 (both endogenous and
plasmid derived) in the cell culture was determined by
real-time PCR (Figure 2B). As expected, the levels of
rpS13 mRNA in the cell cultures treated with plasmids
coding for rpS13 (either pECFP-S13 or pECFP-S13-int1)
were much higher than in the cell cultures treated with the
original vector or in the untreated culture. It means that
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pool of mRNA coding for rpS13 consists largely of the
plasmid-derived mRNA. Remarkably, the level of rpS13
mRNA in cells transfected with pECFP-S13-int1 was
about four times less than that in the cells transfected with
the intronless construction pECFP-S13, even though the
levels of GAPDH mRNA were about the same. The result
is consistent with the hypothesis that rpS13 might regulate
the level of protein expression via feedback on splicing and
it suggests that the target is intron 1, while the result does
not exclude both other intron-dependent mechanisms and
possible eﬀect of rpS13 on splicing of some other pre-
mRNAs.
Ribosomal proteinS13binds specifically topre-mRNA
containing intron1and inhibits splicing of intron1 in vitro
To test whether rpS13 could bind directly to the ﬁrst
intron and to study the eﬀect of the protein on splicing
in vitro, we made a transcript containing intron 1 and
ﬂanking exon sequences (transcript S13INT) (Figure 3A).
The ability of recombinant ribosomal proteins S13, S10
Figure 1. Intron 1 in RPS13 gene of mammals and birds is evolutionary conserved. Generated by the ECR browser (35) graphic plot of genomic
alignment and comparative analysis with the genes coding for rpS13 in dog, mouse, rat and chicken. Smooth peaks represent levels of sequence
identity. Exons coloured in blue, introns in pink. Intron 1 is marked by brace.
Figure 2. Overexpression of rpS13 in mammalian cells suppresses the expression of mRNA from a minigene containing intron 1. (A) Diagrams
of vectors pECFP-S13 and pECFP-S13-int1. (B) Relative amount of mRNA coding for rpS13 (both endogenous and plasmid-derived) in HEK
293 cells. Non-transfected cells (column 1), cells transfected with pECFP-N1 (column 2), cells transfected with pECFP-S13 (accepted as 100 arbitrary
units, column 3) and cells transfected with pECFP-S13-int 1 (column 4). Experiments made in triplicate; error bars are shown. For standardization
of the quantity of RNA in the samples primers speciﬁc to GAPDH cDNA were used. Dispersal of amount of GAPDH cDNA in the samples
that reﬂects total amount of RNA was  25% from average value.
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32P-labelled RNA was followed by
nitrocellulose binding (Figure 3B). To reduce the risk of
non-speciﬁc binding due to electrostatic interaction
between the positively charged ribosomal proteins and
negatively charged RNA, protein binding was measured in
250mM KCl. The apparent association constant for
rpS13 was 5.0 10
7M
 1, 4-fold higher than the constant
for rpS16; rpS10 showed little binding to S13INT.
Unlabelled S13INT, used as a competitor, eﬀectively
displaced labelled S13INT from the complex with rpS13
Figure 3. rpS13 preferentially binds to its RNA containing the ﬁrst intron (S13INT). (A) Schematic diagram of human RPS13 gene showing the
location of the exons (numbered shadowed boxes) and a scheme of S13INT synthesis. (B) Isotherms of binding of
32P-labelled S13INT to rpS13
(ﬁlled circles), rpS16 (open circles) and rpS10 (ﬁlled triangles). (C) Displacement of
32P-labelled S13INT from its complex with rpS13 by competition
with unlabelled RNAs: S13INT (ﬁlled circles), AdML (open circles) and poly (AU) (ﬁlled triangles). (D) Isotherms of binding of various
32P-labelled
pre-mRNA fragments containing intron 1 to rpS13: S13INT (ﬁlled circles), S13INTm (open circles), rpS16 pre-mRNA fragment (ﬁlled triangles) and
rpS26 pre-mRNA fragment (open triangles). (E) Immunoprecipitation of rpS13 associated with
32P-labelled RNA in nuclear extract. The mixture
of S13INT, rpS17 and rpS26 RNA was separated by denaturing PAGE after isolation on beads either charged with antibodies against rpS13 (lane 1),
or uncharged (unspeciﬁc sorbtion, lane 2); lane 3, aliquot of the initial mixture; lane 4, aliquot of the sample containing RNAs unbound to the
beads charged with antibodies. Columns illustrate the proportion of each RNA transcript in the initial mixture (‘before’) and in the mixture isolated
from nuclear extract (‘after’).
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adenovirus major late (AdML) RNA or poly(AU)) were
much weaker (Figure 3C).
The ability of rpS13 to bind to other intron-containing
RNAs was examined with transcripts corresponding to
portions of rpS16 and rpS26 pre-mRNAs of comparable
length (Figure 3D). The aﬃnity of rpS13 for the non-
cognate pre-mRNAs was much less as compared with that
for S13INT, indicating the speciﬁcity of interaction of
rpS13 with S13INT. The aﬃnity of rpS13 for a fragment
of the cognate pre-mRNA was also tested in HeLa nuclear
extract using immunoprecipitation. For this purpose,
recombinant rpS13 was incubated in nuclear extract with
32P-labelled S13INT and transcripts derived from rpS17,
and rpS26 pre-mRNAs. RpS13 was immunoprecipitated,
and the transcripts thereby recovered were separated on
a polyacrylamide gel. The results are presented in Figure.
3E. The proportion of S13INT was higher after immuno-
selection. Therefore, we conclude that rpS13 discriminates
between these alternative RNA sequences in favour of
its own pre-mRNA.
To establish whether the binding of rpS13 to S13INT
aﬀected splicing in vitro, reactions were done with two
labelled substrates, S13INT and a fragment of rpS16
pre-mRNA, in the same reaction mixture. Incubation of
S13INT under splicing conditions resulted in the forma-
tion of a 112nt-long product corresponding to the spliced
exons (Figure 4A). In vitro splicing of rpS16 pre-mRNA
produced RNA of 229nt (spliced exons) and splicing
intermediates (Figure 4A). The addition of increasing
concentrations of rpS13 to reaction mixtures containing
both the pre-mRNAs caused complete inhibition of
splicing of S13INT at a protein concentration of 8mM,
whereas the suppression of splicing of the non-cognate
rpS16 pre-mRNA was much weaker (Figure 4A). The
non-cognate ribosomal proteins rpS10 and rpS16 barely
aﬀected S13INT splicing (Figure 4B). This implies
that rpS13 is able to suppress splicing of the cognate
pre-mRNA in vitro by a feedback mechanism.
Binding site of rpS13on its pre-mRNA fragment locates
closely tothe 5’- and 3’- splicesites
To ascertain how rpS13 binding may prevent splicing
of the S13INT transcript, we attempted to establish
the rpS13-binding site using an enzymatic footprinting
experiment. RNA footprints detect either the direct
protection of phosphodiester bonds by the bound protein
or rearrangements of the RNA spatial structure caused by
protein binding. A prediction of the S13INT secondary
structure using Sfold 2.0 (http://sfold.wadsworth.org/
index.pl) (38) revealed that folded S13INT represents an
ensemble of molecules with similar tightly folded struc-
tures formed with several extended stems and few loops.
An ensemble centroid with a minimum free energy (G37)
equal to  88.5kcal/mol is shown in Figure 5A. Taking
into account the high (65%) GC-content of the S13INT
sequence, we infer that a structure at least similar to
this would be formed by pre-mRNA before addition to
nuclear extract. Therefore, we carried out footprinting of
free RNA and the RNA in the binary complex
(rpS13 S13INT) under conditions when more than 90%
of the RNA was bound to the protein. Three RNases,
T1, T2 and V1, were employed in the experiments.
The positions of cleavages identiﬁed by primer extension
analysis using two diﬀerent primers are presented in
Figure 5B. The footprinting data generally supported the
secondary structure proposed for S13INT. Seven phos-
phodiester bonds within S13INT changed their accessi-
bility to RNases due to rpS13 binding (Figure 5A). Two of
them (cleavages 50 to C46 and G53) are located in the
vicinity of the 50 splice site, another two (cleavages 50 to
A192 and G193) are close to the 30 splice site and three
sites (cleavages 50 to C76 and to neighbouring residues
C162 and A164) are intronic, somewhat distant from the
splice sites.
To test whether the sites aﬀected by rpS13 could be
involved in protein binding, we introduced mutations in
S13INT close to these regions. The trinucleotides CCC
(positions 44–46) and AAG (positions 191–193) were
replaced with AGA and CCC, respectively, (S13INTm).
The aﬃnity of rpS13 for S13INTm was substantially
smaller than that for S13INT (Figure 3D), indicating that
the mutations really disturbed the protein-binding site.
S13INTm was reactive in splicing in vitro and it generated
the same splicing pattern as S13INT, but it was less
sensitive to inhibition by rpS13 (Figure 4C). These results
suggest that rpS13 inhibits splicing of its own pre-mRNA
due to its binding close to the splicing sites in intron 1.
DISCUSSION
Ribosomal proteins are very abundant cellular proteins
that are capable of binding to diﬀerent RNA species.
Recent investigations have demonstrated that eukaryotic
ribosomal proteins are associated with newly transcribed
RNA Pol II transcripts (39,40). Thus, the presence of
27 ribosomal proteins in sites of active transcription in
Drosophila salivary gland cells was shown by means of
chromosomal immunostaining and in situ hybridization
(39). Method of chromatin immunoprecipitation revealed
that ribosomal proteins in Saccharomyces cerevisiae
associate with nascent RNP complexes within nucleus
(40). Ribosomal proteins were also found in spliceosomal
complexes in human cells (41). Although, it was assumed
in these cases that nascent transcripts were bound non-
speciﬁcally, the example of human rpS13 suggests that
there are also speciﬁc interactions between ribosomal
proteins and their pre-mRNAs that may have functional
signiﬁcance.
Earlier, it was shown that introns in a few eukaryotic
ribosomal protein genes participate in regulation of
expression (22,24). These introns, as a rule, are short
and bear conserved regulatory elements. Our search of
the RPS13 gene demonstrated that intron 1 is conserved
within the genomes of higher eukaryotes (Figure 1). This
is consistent with a role in the regulation of expression.
The constructions pECFP-S13 and pECFP-S13-int1
used for the in vivo experiments diﬀered in the presence
of intron 1 of RPS13 gene in the latter construction.
Cells transfected with pECFP-S13-int1 overproduced
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premature transcript produced from pECFP-S13-int1 was
correct. The 4-fold decrease in rpS13 mRNA as compared
with those in the cells transfected with pECFP-S13
suggested a connection between the presence of intron 1
in the premature transcript and the level of rpS13 mRNA
in the cells. One possibility is that rpS13 inhibited splicing
of intron 1, decreasing the total rpS13 mRNA level in
the transfected cells. However, other intron-dependent
pathways remained possible too; one example might be
targeting by rpS13 of nuclease activity to the pre-mRNA.
Due to its high positive charge, rpS13, like other
Figure 4. rpS13 speciﬁcally inhibits in vitro splicing of the S13INT transcript. (A) Eﬀect of rpS13 on splicing of S13INT and rpS16 pre-mRNA
fragment. Products of splicing were separated on 6% denaturing PAAG. Time course reactions of the transcripts alone (lanes 1–4 and 10–13) and 2h
incubation under splicing conditions of the transcripts taken together in the presence of rpS13at concentrations of 0.3mM (lane 6), 1mM (lane 7),
3mM (lane 8), 8mM (lane 9) or without the protein (lane 5). Positions of RNAs on the gel and their lengths are denoted on left (for S13INT) and on
right (for rpS16 pre-mRNA). Arrows on the gel (lane 9) indicate presence of the mRNA product for rpS16 pre-mRNA splicing and its absence
for S13INT. (B) Eﬀect of rpS13, rpS16 and rpS10 on the S13INT splicing. Products of S13INT splicing after 2h incubation under splicing conditions
in the presence of rpS13 (lanes 2–4), rpS10 (lanes 5–7) and rpS16 (lanes 8–10) at concentrations of 1mM (lanes 2, 5, 8), 5mM (lanes 3, 6, 9), 8mM
(lanes 4, 7, 10) or without protein (lane 1), separated on 6% denaturing gel. The positions of the RNAs are indicated on right. (C) Comparison of
eﬀects of rpS13 on the in vitro splicing of S13INT transcript and of the transcript mutated in the vicinity of both the 50 and 30 splice sites (S13INTm).
Lanes 1–3 and 10–12—time-course reactions. Splicing products after 2h incubation of S13INT (lanes 4–6) and S13INTm (lanes 7–9) under splicing
conditions at the presence of rpS13at the concentration 1mM (lanes 4 and 7), 3mM (lanes 5 and 8), 6mM (lanes 6 and 9). Arrows indicate presence
of the mRNA product with S13INTm (lane 9) and its absence with S13INT (lane 6). The diagram below represents quantiﬁcation of the gel data.
Each column represents the ratio of the intensities of bands for the mRNA product and the pre-mRNA on the respective lane on the gel in arbitrary
units. The height of column is proportional to the splicing eﬃciency. White columns are for S13INT, grey ones are for S13INTm. Columns
are grouped in pairs for splicing reactions carried out under the same conditions.
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RNA. Actually, the in vitro binding assays showed that
rpS13 was able to bind to non-cognate pre-RNAs, but this
binding was much weaker than its binding to cognate pre-
mRNA containing intron 1. Moreover, rpS13 was able to
inhibit splicing in vitro of this fragment, whereas other
ribosomal proteins did not do so; at the same time, rpS13
had little eﬀect on the splicing of non-cognate pre-
mRNAs. Hence, it seemed probable that rpS13 would
interact with regions in the pre-mRNA that are necessary
for splicing.
The footprinting experiments with S13INT in the
complex with rpS13 revealed changes in accessibility to
RNases for several internucleotide phosphodiester bonds
that are located both in regions of the RNA close to 50 and
30 splice sites and in the vicinity of them (Figure 5). Taking
into account that ribosomal proteins upon their binding to
rRNA, as a rule, do not introduce major changes into its
structure (42,43) we consider it more likely that the
footprints arose from protein binding rather than from
S13INT structural rearrangements. Either the regions of
S13INT containing the 50 and 30 splice sites are spatially
drawn together and form the rpS13-binding site or several
protein molecules bind to diﬀerent splice sites.
Although, the binding sites for rpS13 have not been
determined, its prokaryotic homologue, rpS15, has been
shown to recognize RNA structure rather than speciﬁc
sequences. In particular, it recognizes on 16S rRNA an
imperfect double helix with a three-way junction at its
base and G-U/G-C base pairs separated from the junction
by one helical turn (42,44,45). Remarkably, the region
recognized in S13INTby rpS13 contains a helix formed by
nucleotides from 39 to 64, with base pairs G48–U55 and
G49–C54 approximately one turn from the RNA three-
way junction (Figure 5A). The 50 splice site in S13INT is
located within this helix. Moreover, we found that
Figure 5. rpS13 binds to S13INT in the vicinity of the splice sites. Footprinting of S13INT transcript in the complex with rpS13. (A) Ensemble
centroid of S13INT calculated by Sfold 2.0 (38). Positions of rpS13 protection from RNase cleavage are shown by arrows marked with the respective
nucleotide positions. Boxes with arrows indicate positions of the 50 and 30 splice sites. (B) Primer extension analysis of the S13INT transcript cleaved
with RNAses T1, T2 and V1 free ( ) or in the complex with rpS13 (+). Lanes A, C, G and T correspond to the sequencing reactions. Positions
of the nucleotides protected by the protein from RNase cleavage (footprints) are marked by arrows. Primers complementary to positions 103–116
(panel 1) and 235–250 (panels 2 and 3) of S13INT transcript were used in the study.
Nucleic Acids Research, 2007, Vol. 35, No. 19 6421disruption of this helix structure by mutations in positions
44–46 (together with mutations in positions 191–193)
reduces the rpS13 binding (Figure 3D). The similarity with
the binding site of rpS15 is consistent with the possibility
that the footprints (at least close to the 50 splice site) arose
from rpS13 binding to corresponding sites in S13INT.
Our ﬁndings suggest that the inhibition of splicing
of the rpS13 pre-mRNA by an increase in rpS13 con-
centration results from the binding of rpS13 to the
pre-mRNA near the splicing signals within intron 1.
The consequences of this binding for splicing reactions
are unknown. However, if splicing of intron 1 is blocked,
intron-retaining RNA may be formed, as described for
some other eukaryotic ribosomal protein mRNAs (22,24),
and it may be degraded by NMD (Figure 6). Such
a mechanism is likely to work most eﬃciently with
terminal introns adjacent to short terminal exons, in
which impediments to splicing are to lead to either
skipping or the activation of cryptic sites. Interestingly,
both E. coli (46,47) and Thermus thermophilus (48) rpS15
proteins have a regulatory function. The latter binds to its
own mRNA and represses its own translation by a
feedback mechanism (48).
The autoregulation of expression by eukaryotic ribo-
somal proteins appears to operate by a variety of
mechanisms. Thus, rpL12 of C. elegans inhibits constitu-
tive splicing of its own pre-mRNA and stimulates
alternative splicing in intron 2 (24), whereas human
rpS26 inhibited both constitutive and alternative splicing
of its intron 1 (21). A rise in ribosomal protein L1
concentration in oocytes of Xenopus laevis leads to the
formation and rapid degradation of rpL1 mRNA iso-
forms containing unremoved introns 2 and 3 (49), and
rpL30 of S. cerevisiae inhibits not only splicing of its own
pre-mRNA by binding to the intron, but also translation
of its own mRNA (20). Feedback autoregulation may
have evolved independently for some or all ribosomal
proteins, but it would be unsurprising if the major process
subject to regulation was splicing. The subtlety and
complexity of splicing suggest that the process might be
unusually delicate and susceptible to perturbation.
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